H-Wave® Device Stimulation for Post-operative Rotator Cuff Repair Surgery

Part of paid clinical trials in Overland Park, Kansas.

Sponsor
Electronic Waveform Lab
Study ID
NCT07501949
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Rotator Cuff Tear Surgical Repair

Eligibility Criteria

Sex
ALL
Age
18 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • Routine post-surgical care plus H-Wave® Device Stimulation (HWDS) — DEVICE
    Routine post-surgical care plus H-Wave® Device Stimulation (HWDS)
  • Routine post-surgical care — OTHER
    Routine post-surgical care: standard protocols per procedure, including access to opioid and non-opioid pain medications

Study Details

The goal of this intent-to-treat study is to evaluate the efficacy of H-Wave Device Stimulation following rotator cuff repair surgery. It is hypothesized that HWDS initiated immediately upon home arrival following rotator cuff repair will not only result in earlier range of motion recovery, but also in better pain relief, medication reduction, sleep quality, and functional recovery. The participants will be randomized into two groups: (a) Routine post-surgical care: standard protocols per procedure, including access to opioid and non-opioid pain medications, (b) Routine post-surgical care plus H-Wave® Device Stimulation (HWDS); and will be followed for 3 months post-surgery.

Key Dates

Start date
Apr 1, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Routine post-surgical care plus H-Wave® Device Stimulation (HWDS)
  • Active Comparator: Routine post-surgical care

Primary Outcome Measure

Change in Pain Medication Usage [ Time Frame: Baseline, 6-8days, 3-4weeks, 2 months and 3 months ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
SanoOverland ParkKansas66211
Becky Jones
512-468-8357
Michael J. Dempewolf, DO, MBA
816-525-2840
Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR)
Matthew Dagget, DO, MBA (SUB_INVESTIGATOR)
Andrew Witte, DO, MBA (SUB_INVESTIGATOR)
Matthew Cullen, DO (SUB_INVESTIGATOR)
John Swab, DO (SUB_INVESTIGATOR)
Christopher Eckland, DO (SUB_INVESTIGATOR)
Daniel Farrell, MS, MD, FAAOS (SUB_INVESTIGATOR)
SanoKansas CityMissouri64151
Becky Jones
512-468-8357
Michael J. Dempewolf, DO, MBA
816-525-2840
Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR)
Matthew Dagget, DO, MBA (SUB_INVESTIGATOR)
Andrew Witte, DO, MBA (SUB_INVESTIGATOR)
Matthew Cullen, DO (SUB_INVESTIGATOR)
John Swab, DO (SUB_INVESTIGATOR)
Christopher Eckland, DO (SUB_INVESTIGATOR)
SanoLee's SummitMissouri64064
Becky Jones
512-468-8357
Michael J. Dempewolf, DO, MBA
816-525-2840
Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR)
Matthew Dagget, DO, MBA (SUB_INVESTIGATOR)
Andrew Witte, DO, MBA (SUB_INVESTIGATOR)
Matthew Cullen, DO (SUB_INVESTIGATOR)
John Swab, DO (SUB_INVESTIGATOR)
Christopher Eckland, DO (SUB_INVESTIGATOR)
SanoRaymoreMissouri64083
Becky Jones
512-468-8357
Michael J. Dempewolf, DO, MBA
816-525-2840
Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR)
Matthew Dagget, DO, MBA (SUB_INVESTIGATOR)
Andrew Witte, DO, MBA (SUB_INVESTIGATOR)
Matthew Cullen, DO (SUB_INVESTIGATOR)
John Swab, DO (SUB_INVESTIGATOR)
Christopher Eckland, DO (SUB_INVESTIGATOR)

Find similar trials in Overland Park, KS